The JAMA newsletter includes an overview of the diagnosis and management of resistant hypertension. A summary of the ACC/AHA 2025 guidelines for the management of hypertension in adults is also published. The newsletter also includes perspectives on the FDA's draft guidance on Bayesian methods in clinical trials. These perspectives focus on protecting scientific integrity and evidentiary standards. A podcast focused on the diagnosis and management of resistant hypertension is also included.